The extent of old posterodiaphragmatic myocardial infarction has been assessed by vector and scalar measurements of the Frank orthogonal ECG. 121 men angiographically proven to have coronary artery disease were selected on the basis of a Q/R amplitude ratio of greater than or equal to 0.25 and T wave inversion in lead aVF. They were grouped according to varying degrees of severity and the extent of wall motion disorders of the diaphragmatic and posterobasal segment of the left ventricle: (1) hypokinesis, n = 24; (2) akinesis or dyskinesis of one segment, n = 60; (3) akinesis and/or dyskinesis of two segments, n = 34. Discriminant analysis was performed by entering 11 QRS measurements. Rao's selection method permitted the 5 most decisive variables to be used for the actual analysis. They were the sum of elevation angles of the 5 initial vectors obtained at 0.01 sec intervals, the sum of magnitudes of the 3 terminal vectors at 0.01 sec intervals, the magnitude of the -0.03 sec terminal vector, the magnitude of the -0.04 sec terminal vectors, and the sum of duration of R in lead Y + R in lead Z. The classification routine could then identify correctly 70.6% of group 3, but only 50% and 46.7% of groups 1 and 2, respectively. 20.6% and 8.8% of group 3 were falsely predicted to be members of groups 2 and 1, respectively. Only 8.3% of group 1 were falsely classified as members of group 3. Thus, the electrocardiographic measurements enable transmural myocardial infarction to be predicted with confidence when the patient is classified as member of group 3.(ABSTRACT TRUNCATED AT 250 WORDS)
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0167-5273(84)90057-3 | DOI Listing |
J Interv Card Electrophysiol
January 2025
Cardiovascular Department, University of Texas Medical Branch, Galveston, TX, USA.
Background: Ventricular tachycardia (VT) in patients with cardiac sarcoidosis (CS) can lead to sudden cardiac death. The role of ventricular tachycardia ablation (VTA) in CS has been investigated in a few small, single-center, and larger observational studies, but the evidence still needs to be provided. This study aimed to investigate the clinical outcomes of VTA in patients with CS admitted with a diagnosis of VT.
View Article and Find Full Text PDFJ Cardiovasc Transl Res
January 2025
Clinical Laboratory of Tianjin Chest Hospital, 261 Taierzhuang South Road, Tianjin, 300222, Jinnan District, China.
The prognostic value of differentially expressed senescence-related genes(DESRGs) in ST-segment elevation myocardial infarction(STEMI) patients is unclear. We used GEO2R to identify DESRGs from GSE60993 and performed functional enrichment analysis. We built an optimal prognostic model with LASSO penalized Cox regression via GSE49925.
View Article and Find Full Text PDFEur Heart J Acute Cardiovasc Care
December 2024
Department of Cardiology, Angiology, Hemostaseology and Medical Intensive Care, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Background: The impact of systemic inflammation in acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is still a matter of debate. The present ECLS-SHOCK sub-study investigates the association of C-reactive protein (CRP) levels with short-term outcomes in patients with AMI-CS.
Methods: Patients with AMI-CS enrolled in the multicenter, randomized ECLS-SHOCK trial between 2019 and 2022 were included.
Clin Chem Lab Med
January 2025
Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Eur Heart J
December 2024
Department of Cardiology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Background And Aims: Current estimates for the lifetime risk to develop heart failure with either a reduced (HFrEF) or preserved ejection fraction (HFpEF) and their associated risk factors are derived from two studies from the USA. The sex-specific lifetime risk and population attributable fraction of potentially modifiable risk factors for incident HFpEF and HFrEF are described in a large European community-based cohort with 25 years of follow-up.
Methods: A total of 8558 participants from the PREVEND cohort were studied at baseline from 1997 onwards and followed until 2022 for cases of new-onset HFrEF (ejection fraction < 50%) and HFpEF (ejection fraction ≥ 50%) by assessment of hospital records.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!